Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Polaryx Therapeutics, Inc. (PLYX) had Return on Investments of -12.62% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-1.38M |
|
-- |
|
-- |
|
$1.38M |
|
$-1.38M |
|
-- |
|
$-1.38M |
|
$-1.38M |
|
$-1.38M |
|
$-1.38M |
|
$-1.38M |
|
$-1.38M |
|
$-1.38M |
|
$-1.38M |
|
48.28M |
|
48.28M |
|
$-0.03 |
|
$-0.03 |
|
| Balance Sheet Financials | |
$11.81M |
|
-- |
|
-- |
|
$11.81M |
|
$0.87M |
|
-- |
|
-- |
|
$0.87M |
|
$10.94M |
|
$10.94M |
|
$10.94M |
|
49.85M |
|
| Cash Flow Statement Financials | |
$-3.43M |
|
-- |
|
$9.83M |
|
$5.14M |
|
$11.54M |
|
$6.40M |
|
$0.47M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.53 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.43M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-12.62% |
|
-12.62% |
|
-11.68% |
|
|
Return on Investments |
-12.62% |
$0.22 |
|
$-0.07 |
|
$-0.07 |
|